Update of non-pharmacological therapy for heart failure /
Saved in:
Imprint: | Singapore : Springer, 2020. |
---|---|
Description: | 1 online resource (122 p.) |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12605605 |
Table of Contents:
- Intro
- Contents
- Chapter 1: Overview
- 1.1 Guideline-Directed Medical Therapy (GDMT) in Chronic Heart Failure
- 1.2 Drugs for Acute Heart Failure
- 1.3 New Drugs for HFrEF
- 1.4 Outline of Non-pharmacological Therapy for Heart Failure
- References
- Chapter 2: Device Monitoring
- 2.1 Introduction
- 2.2 Pulmonary Artery Pressure Monitoring (CardioMEMS™)
- 2.3 Pulmonary Congestion Monitoring (Remote Dielectric System [ReDS])
- 2.4 Hemodynamic Monitoring in LVAD Patients
- References
- Chapter 3: CRT/ICD
- 3.1 Introduction
- 3.2 Indications for CRT
- 3.3 CRT in Atrial Fibrillation
- 3.4 Timing of CRT Introduction
- 3.5 CRT Programming
- 3.6 Attempts to Address Nonresponders
- 3.7 The Future of CRT
- References
- Chapter 4: Noninvasive Positive Pressure Ventilation
- 4.1 Introduction
- 4.2 CPAP and NPPV (Including ASV) for Acute Pulmonary Edema and Acute Heart Failure, and the Mechanism of Effectiveness of Positive Pressure Treatment for Hemodynamics
- 4.3 CPAP and NPPV for Sleep Apnea Associated with Heart Failure and the Mechanism of Effectiveness of Positive Pressure Treatment for Apnea
- 4.4 Beneficial Effect of ASV Therapy for Chronic Heart Failure
- 4.5 Is ASV Therapy Really Harmful? Beyond the SERVE-HF Study
- 4.6 Conclusion
- References
- Chapter 5: Comprehensive Cardiac Rehabilitation
- 5.1 Treatments for HF
- 5.2 Effects of Exercise Therapy
- 5.3 Exercise Prescription for HF
- 5.4 Sarcopenia in HF
- 5.5 Resistance Exercise
- 5.6 Aerobic and Resistance Exercises in HF
- 5.7 Comprehensive Cardiac Rehabilitation
- References
- Chapter 6: IABP/ECMO
- 6.1 IABP
- 6.1.1 Overview
- 6.1.2 IABP for Cardiogenic Shock (CS): Current Evidence
- 6.1.2.1 Definition of CS
- 6.1.2.2 IABP for CS
- 6.1.3 Clinical Practice and Future Perspective
- 6.2 Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
- 6.2.1 Overview
- 6.2.2 VA-ECMO for CS: Current Evidence
- 6.2.3 Indications and Contraindications
- 6.2.4 Clinical Practice
- 6.2.4.1 Cannulation
- 6.2.4.2 Daily Management
- 6.2.4.3 Weaning
- 6.2.5 Complications
- References
- Chapter 7: Impella
- 7.1 Impella Left Ventricular Support System
- 7.2 Indication, Background, and Complication of Impella
- 7.3 ECPELLA (ECMO Plus Impella)
- 7.4 The Methodology of Impella Delivery into the Left Ventricle
- 7.5 Management Practice During Impella Support
- 7.6 Management of Hemolysis
- 7.7 Next Step from Impella
- References
- Chapter 8: MitraClip
- 8.1 Introduction
- 8.2 Edge-to-Edge Repair (MitraClip®)
- 8.3 MitraClip® in Degenerative MR
- 8.4 MitraClip® in Functional MR
- References
- Chapter 9: MVP/LV Plasty
- 9.1 Introduction
- 9.2 Partial Left Ventriculectomy
- 9.2.1 Surgical Procedure
- 9.2.2 Outcomes
- 9.3 Mitral Valve Plasty
- 9.3.1 Restrictive Mitral Annuloplasty
- 9.3.2 Subvalvular Procedures
- 9.3.3 Guidelines for Mitral Valve Surgery in Secondary MR